pathway_id	pathway_name	entitya	regulator_location	typea	ida	databasea	entityb	target_location	typeb	idb	databaseb	effect	mechanism	residue	sequence	tax_id	cell_data	tissue_data	modulator_complex	target_complex	modificationa	modaseq	modificationb	modbseq	pmid	direct	notes	annotator	sentence	signor_id
SIGNOR-LBC	Luminal Breast Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									24743741	f			Activation of PDGFRα stimulates proliferation of PDGFRα(+) cells through PI3K-Akt and MEK2-MAPK signaling pathways, and aberrant accumulation of PDGFRα(+) cells was conspicuous in muscles of patients with both genetic and non-genetic muscle diseases.	SIGNOR-257606
SIGNOR-LBC	Luminal Breast Cancer	FGFR1	receptor	protein	P11362	UNIPROT	FRS2	receptor	protein	Q8WU20	UNIPROT	up-regulates activity	phosphorylation			10116	BTO:0002809								9182757	t		fspada	In this report, we demonstrate that FGF stimulation induces tyrosine phosphorylation of a novel lipid anchored docking protein, termed FRS2, that forms a complex with Grb2/Sos, thus linking FGF-receptor activation to the Ras/MAPK signaling pathway.	SIGNOR-236944
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	E2F1	factor	protein	Q01094	UNIPROT	up-regulates activity	phosphorylation			9606									23616010	t		lperfetto	Erk also undergoes rapid translocation into the nucleus, where it phosphorylates and activates a variety of transcription factor targets, including sp1, e2f, elk-1, and ap1.	SIGNOR-233526
SIGNOR-LBC	Luminal Breast Cancer	PDPK1		protein	O15530	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates	phosphorylation			9606									21798082	t		lperfetto	Positive feedback involves mtorc2, which phosphorylates akt at serine 473, a phosphorylation required for maximum activation of akt in addition to phosphorylation at threonine 308 by pdk1.	SIGNOR-244396
SIGNOR-LBC	Luminal Breast Cancer	PDPK1		protein	O15530	UNIPROT	MEK1/2		proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates activity	phosphorylation			9606	BTO:0000007								15175348	t		lperfetto	In vitro kinase assay revealed that the direct targets of pdk1 in the mapk pathway were the upstream mapk kinases mek1 and mek2. The identified pdk1 phosphorylation sites in mek1 and mek2 are ser222 and ser226, respectively, and are known to be essential for full activation	SIGNOR-244934
SIGNOR-LBC	Luminal Breast Cancer	PDPK1		protein	O15530	UNIPROT	MEK1/2		proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates	phosphorylation			9606									15175348	t		lperfetto	The identified pdk1 phosphorylation sites in mek1 and mek2 are ser222 and ser226, respectively, and are known to be essential for full activation.	SIGNOR-244938
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	IRS1		protein	P35568	UNIPROT	up-regulates activity	phosphorylation	Tyr896	EPKSPGEyVNIEFGS	10029	BTO:0000246								7651388	t		lperfetto	Therefore, during insulin stimulation irs-1 undergoes tyrosine phosphorylation, and a portion of tyrosine phosphorylated irs-1 associated with the insulin receptor. The insulin receptor substrate-1 (irs-1) is rapidly phosphorylated on several tyrosine residues by the activated insulin receptor. Insulin signals are mediated through tyrosine phosphorylation of specific proteins such as insulin receptor substrate 1 (irs-1) and shc by the activated insulin receptor (ir).	SIGNOR-236745
SIGNOR-LBC	Luminal Breast Cancer	FGFR1	receptor	protein	P11362	UNIPROT	FGFR1	receptor	protein	P11362	UNIPROT	up-regulates	phosphorylation	Tyr307	IGPDNLPyVQILKTA	9606									8443592	t		lperfetto	Tyrosine residues 154 and 307, which are in the extracellular domain of transmembrane receptor isoforms and are in an unusual sequence context for tyrosine phosphorylation, were also phosphorylated.	SIGNOR-98630
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	SOS1		protein	Q07889	UNIPROT	down-regulates activity	phosphorylation	Ser1167	ESAPAESsPSKIMSK	9534	BTO:0004055								8816480	t		lperfetto	In this report, we describe the identification of five map kinase sites (s-1137, s-1167, s-1178, s-1193, and s-1197) on hsos1Replacing the MAP kinase phosphorylation sites with alanine residues results in an increase in the binding affinity of Grb2 to hSos1	SIGNOR-244584
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	SOS1		protein	Q07889	UNIPROT	down-regulates activity	phosphorylation	Ser1197	KAYSPRYsISDRTSI	9534	BTO:0004055								8816480	t		lperfetto	In this report, we describe the identification of five map kinase sites (s-1137, s-1167, s-1178, s-1193, and s-1197) on hsos1Replacing the MAP kinase phosphorylation sites with alanine residues results in an increase in the binding affinity of Grb2 to hSos1	SIGNOR-244588
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	SOS1		protein	Q07889	UNIPROT	down-regulates	phosphorylation	Ser1193	QPTSKAYsPRYSISD	9606									20724475	t		lperfetto	ERK activation was sufficient for the SOS1 phosphorylation and resulting inhibition of EGF-induced Ras activation. This result also showed that SOS1 could be phosphorylated by ERK in the absence of association with EGFR at the plasma membrane, which is a phosphotyrosine-dependent process. 	SIGNOR-244747
SIGNOR-LBC	Luminal Breast Cancer	BRAF		protein	P15056	UNIPROT	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	up-regulates activity				9606									21900390	f		miannu	RAF, a cytoplasmic serine-threonine protein kinase, is a member of the RAS-RAF-MEK-ERK cell-signaling pathway [also known as the MAP kinase (MAPK) pathway], and it plays an essential role in mediating cellular differentiation, proliferation, senescence, and survival in response to extracellular cues. Raf phosphorylates and activates MAP-ERK kinase (MEK), which phosphorylates and activates extracellular signal-regulated kinase (ERK).	SIGNOR-260082
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090									20219869	f		areggio	Furthermore, stimulation of myoblasts with CCL2, CCL3, or CCL4 was sufficient to induce phosphorylation and activation of ERK1/2. This outcome may be functionally important because ERK1/2 activation is a component of the pathway through which many mitogenic growth factors can stimulate cell proliferation.	SIGNOR-255120
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	INSR	receptor	protein	P06213	UNIPROT	up-regulates activity	phosphorylation	Tyr1361	SYEEHIPyTHMNGGK	-1									3166375	t		lperfetto	This approach revealed that insulin stimulates autophosphorylation of the insulin-receptor beta-subunit in vitro on at least seven tyrosine residues distributed among three distinct domainsAt least two further tyrosine residues appeared to be phosphorylated after those in domains 2 and 3. These residues probably residue within a domain lying in close proximity to the inner face of the plasma membrane containing tyrosines 953, 960 and 972	SIGNOR-233560
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	SOS1		protein	Q07889	UNIPROT	down-regulates activity	phosphorylation			9606		BTO:0000763;BTO:0000149							20724475	t		lperfetto	ERK activation was sufficient for the SOS1 phosphorylation and resulting inhibition of EGF-induced Ras activation. This result also showed that SOS1 could be phosphorylated by ERK in the absence of association with EGFR at the plasma membrane, which is a phosphotyrosine-dependent process. 	SIGNOR-244591
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	Survival	phenotypesList	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606	BTO:0000876	BTO:0001103							11602185	f		apalma	The GM-CSF promoted cell survival and proliferation correlated with MEK-1 dependent ERK1/2, Elk-1 and CREB phosphorylation and Egr-1, c-Fos expression as well as with increased STAT-5, AP-1, c-Myb and NF-kappaB DNA-binding.	SIGNOR-255579
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	IRS1		protein	P35568	UNIPROT	up-regulates activity	phosphorylation	Tyr989	VPSSRGDyMTMQMSC	10116	BTO:0000443								7651388	t		lperfetto	All known IRS proteins contain multiple YXXM motifs that upon phosphorylation by activated insulin receptors A previous study using phosphopeptides suggested that tyrosine-phosphorylated YXXM motifs at positions 608 and 939 in rat IRS-1 bind with high affinity to SH2 domains of p85, and motifs at positions 460 and 987 bind with lower affinity (10).	SIGNOR-235979
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	MEK1/2		proteinfamily	SIGNOR-PF25	SIGNOR	down-regulates activity	phosphorylation			9534	BTO:0004055								14993270	t		lperfetto	We propose that activation of erk during adhesion creates a feedback system in which erk phosphorylates mek1 on t292, and this in turn blocks additional s298 phosphorylation in response to integrin signaling.	SIGNOR-244862
SIGNOR-LBC	Luminal Breast Cancer	TP53	factor	protein	P04637	UNIPROT	MDM2		protein	Q00987	UNIPROT	up-regulates quantity by expression	transcriptional regulation			10090									7958853	f		gcesareni	The p53 tumor suppressor protein trans-activates mdm2 itself, which is therefore considered a component of a p53 negative feedback loop.	SIGNOR-34962
SIGNOR-LBC	Luminal Breast Cancer	FGFR1	receptor	protein	P11362	UNIPROT	FGFR1	receptor	protein	P11362	UNIPROT	up-regulates	phosphorylation	Tyr605	KDLVSCAyQVARGME	9606									12601080	t		lperfetto	Fgfr signaling is under the control of tyrosine phosphorylation to elicit activation of cellular signaling cascades. Ligand binding induces receptor dimerization and transphosphorylation. Fgfr1 contains eleven tyrosine residues (tyr154, tyr280, tyr307, tyr463, tyr585, tyr605, tyr653, tyr654, tyr730 and tyr766), some of which are directly involved regulating the activity of the receptor and others bind to activate substrates leading to the activation of various transduction pathways.	SIGNOR-98634
SIGNOR-LBC	Luminal Breast Cancer	PDPK1		protein	O15530	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates activity	phosphorylation	Thr308	KDGATMKtFCGTPEY	10116		BTO:0000142							10226025	t		lperfetto	Protein kinase B (PKB) is activated by phosphorylation of Thr308 and of Ser473. Thr308 is phosphorylated by the 3-phosphoinositide-dependent protein kinase-1 (PDK1) but the identity of the kinase that phosphorylates Ser473 (provisionally termed PDK2) is unknown.	SIGNOR-244421
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0001103							20219869	f		apalma	ERK1/2 activation is a component of the pathway through which many mitogenic growth factors can stimulate cell proliferation	SIGNOR-256216
SIGNOR-LBC	Luminal Breast Cancer	MEK1/2		proteinfamily	SIGNOR-PF25	SIGNOR	IRS1		protein	P35568	UNIPROT	down-regulates	phosphorylation	Ser307	TRRSRTEsITATSPA	9606		BTO:0000887							11160134	t		lperfetto	Thus, at least three kinases mediate phosphorylation of ser307, including jnk, serine kinases in the pi 3-kinase cascade that are activated byinsulinor igf-1, and mek1-sensitive kinase cascades during tnf-alfa stimulation.	SIGNOR-244784
SIGNOR-LBC	Luminal Breast Cancer	MEK1/2		proteinfamily	SIGNOR-PF25	SIGNOR	MEK1/2		proteinfamily	SIGNOR-PF25	SIGNOR	down-regulates				9606									18481201	f		lperfetto	Pd98059, a specific inhibitor of mek in addition, immunoblot and immunostaining analysis revealed that phosphorylation of erk was increased by treatment with sb203580;whereas pd98059 increased the phosphorylation of p38, which implies a seesaw-like balance between erk and p38 phosphorylation.	SIGNOR-244877
SIGNOR-LBC	Luminal Breast Cancer	TSC1/TSC2		complex	SIGNOR-C101	SIGNOR	RHEB		protein	Q15382	UNIPROT	down-regulates activity	gtpase-activating protein			9606	BTO:0000007								15340059	t		lperfetto	Tsc2 functions as a gap to inhibit rheb activity. Tsc2 displays gap (gtpase-activating protein) activity specifically towards the small g protein rheb and inhibits its ability to stimulate the mtor signaling pathway. It has recently been shown that tsc2 has gtpase-activating protein (gap) activity towards the ras family small gtpase rheb (ras homolog enriched in brain), and tsc1/2 antagonizes the mtor signaling pathway via stimulation of gtp hydrolysis of rheb.	SIGNOR-235895
SIGNOR-LBC	Luminal Breast Cancer	FGFR1	receptor	protein	P11362	UNIPROT	FGFR1	receptor	protein	P11362	UNIPROT	up-regulates	phosphorylation	Tyr583	RRPPGLEyCYNPSHN	10116	BTO:0003293								19224897	t		lperfetto	Autophosphorylation of Y653 is followed by the ordered autophosphorylation of several key tyrosine residues within binding sites for the SH2 or PTB domains of signaling proteins that bind to and are phosphorylated by activated FGFR1. This second-stage autophosphorylation occurs on Y583, in the kinase insert region (a noncatalytic sequence within the kinase domain), followed by autophosphorylation of Y463 in the juxtamembrane region, Y766 in the C-terminal tail, and Y585 in the kinase insert region	SIGNOR-235906
SIGNOR-LBC	Luminal Breast Cancer	GRB2		protein	P62993	UNIPROT	SOS1		protein	Q07889	UNIPROT	up-regulates activity	relocalization			9606	BTO:0001412								10570290	t	GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP	lperfetto	Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85.	SIGNOR-236792
SIGNOR-LBC	Luminal Breast Cancer	PTEN		protein	P60484	UNIPROT	PIK3CA		protein	P42336	UNIPROT	down-regulates activity				9606	BTO:0000938								18794881	f		lperfetto	The pten tumour suppressor is a lipid and protein phosphatase that inhibits phosphoinositide 3-kinase (pi3k)-dependent by dephosphorylating phosphatidylinositol 3,4,5-trisphosphate (ptdinsp(3)).	SIGNOR-209856
SIGNOR-LBC	Luminal Breast Cancer	CDKN2A		protein	P42771	UNIPROT	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606	BTO:0000176								7972006	f			Transfection of the p16INK4 cDNA expression vector into carcinoma cells inhibits their colony-forming efficiency and the p16INK4 expressing cells are selected against with continued passage in vitro. These results are consistent with the hypothesis that p16INK4 is a tumor-suppressor protein and that genetic and epigenetic abnormalities in genes controlling the G1 checkpoint can lead to both escape from senescence and cancer formation.	SIGNOR-259406
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	IRS1		protein	P35568	UNIPROT	up-regulates activity	phosphorylation	Tyr612	TLHTDDGyMPMSPGV	10116	BTO:0000443								11416002	t		lperfetto	All known IRS proteins contain multiple YXXM motifs that upon phosphorylation by activated insulin re- ceptors Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells	SIGNOR-235971
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	IRS1		protein	P35568	UNIPROT	up-regulates activity	phosphorylation	Tyr941	EETGTEEyMKMDLGP	10116	BTO:0000443								7651388	t		lperfetto	All known IRS proteins contain multiple YXXM motifs that upon phosphorylation by activated insulin receptors A previous study using phosphopeptides suggested that tyrosine-phosphorylated YXXM motifs at positions 608 and 939 in rat IRS-1 bind with high affinity to SH2 domains of p85, and motifs at positions 460 and 987 bind with lower affinity (10).	SIGNOR-235975
SIGNOR-LBC	Luminal Breast Cancer	IRS1		protein	P35568	UNIPROT	PIK3CA		protein	P42336	UNIPROT	up-regulates activity	binding			9606		BTO:0000551							20966354	t		lperfetto	Irs proteins are capable of both regulating and activating pi3k, depending on the cell of origin.	SIGNOR-168985
SIGNOR-LBC	Luminal Breast Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	BRAF		protein	P15056	UNIPROT	down-regulates	phosphorylation	Ser364	FGQRDRSsSAPNVHI	9606									10869359	t		lperfetto	We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf	SIGNOR-244152
SIGNOR-LBC	Luminal Breast Cancer	TSC1/TSC2		complex	SIGNOR-C101	SIGNOR	mTORC1		complex	SIGNOR-C3	SIGNOR	down-regulates activity				9606	BTO:0000007;BTO:0001938								12271141	f		lperfetto	These findings strongly implicate the tuberin-hamartin tumor suppressor complex as an inhibitor of mtor	SIGNOR-251527
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	BRAF		protein	P15056	UNIPROT	down-regulates activity	phosphorylation	Ser151	VARSNPKsPQKPIVR	9606	BTO:0000848								21478863	t			We show that overactivation of the MAPK pathway, induced by the oncogenic Ras in melanoma, induces constitutive phosphorylation of BRAF on Ser151 by ERK, which inhibits NRAS-BRAF interaction	SIGNOR-259919
SIGNOR-LBC	Luminal Breast Cancer	CyclinD/CDK4		complex	SIGNOR-C18	SIGNOR	RB1		protein	P06400	UNIPROT	down-regulates activity	phosphorylation	Thr5	tPRKTAAT	-1									9139732	t		llicata	In summary, we have shown evidence that CDK4-cyclin D1 phosphorylates Thr5, Ser249, Thr252, Thr356, Thr373, Ser788, Ser795, Ser807, Ser811, and Thr826 of pRB.	SIGNOR-250762
SIGNOR-LBC	Luminal Breast Cancer	CyclinD/CDK4		complex	SIGNOR-C18	SIGNOR	RB1		protein	P06400	UNIPROT	down-regulates activity	phosphorylation	Ser788	PIPHIPRsPYKFPSS	-1									9139732	t		llicata	In summary, we have shown evidence that CDK4-cyclin D1 phosphorylates Thr5, Ser249, Thr252, Thr356, Thr373, Ser788, Ser795, Ser807, Ser811, and Thr826 of pRB.	SIGNOR-250759
SIGNOR-LBC	Luminal Breast Cancer	CyclinD/CDK4		complex	SIGNOR-C18	SIGNOR	RB1		protein	P06400	UNIPROT	down-regulates activity	phosphorylation	Thr356	DSFETQRtPRKSNLD	-1									9139732	t		llicata	In summary, we have shown evidence that CDK4-cyclin D1 phosphorylates Thr5, Ser249, Thr252, Thr356, Thr373, Ser788, Ser795, Ser807, Ser811, and Thr826 of pRB.	SIGNOR-250760
SIGNOR-LBC	Luminal Breast Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	Survival	phenotypesList	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									16288293	f		miannu	Akt promotes both cell growth and cell survival by inactivating its downstream substrates including GSK3, BAD, FOXO and TSC2.	SIGNOR-251550
SIGNOR-LBC	Luminal Breast Cancer	MDM2		protein	Q00987	UNIPROT	TP53	factor	protein	P04637	UNIPROT	down-regulates quantity by destabilization	ubiquitination			9606									10935507	t		lperfetto	Many posttranslational modifications of p53, such as phosphorylation, dephosphorylation, acetylation and ribosylation, have been shown to occur following cellular stress. Some of these modifications may activate the p53 protein, interfere with MDM2 binding and/or dictate cellular localization of p53.	SIGNOR-80528
SIGNOR-LBC	Luminal Breast Cancer	MDM2		protein	Q00987	UNIPROT	TP53	factor	protein	P04637	UNIPROT	down-regulates quantity by destabilization	ubiquitination			9606									23150757	t		lperfetto	Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity	SIGNOR-199371
SIGNOR-LBC	Luminal Breast Cancer	MDM2		protein	Q00987	UNIPROT	TP53	factor	protein	P04637	UNIPROT	down-regulates quantity by destabilization	ubiquitination			9606	BTO:0000093								22337874	t		lperfetto	The E3 ubiquitin ligase, MDM2, uses a dual-site mechanism to ubiquitinate and degrade the tumor suppressor protein p53, involving interactions with the N-terminal hydrophobic pocket and the acidic domain of MDM2.	SIGNOR-196116
SIGNOR-LBC	Luminal Breast Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	ESR1	factor	protein	P03372	UNIPROT	up-regulates	phosphorylation	Ser106	PLNSVSPsPLMLLHP	9606									11108261	t		lperfetto	Studies using mutants of er-alpha demonstrated that akt increased estrogen receptor activity through the amino-terminal activation function-1 (af-1). Serines s104 s106, s118, and s167 appear to play a role in the activation of er-alpha by akt.	SIGNOR-244247
SIGNOR-LBC	Luminal Breast Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	ESR1	factor	protein	P03372	UNIPROT	up-regulates	phosphorylation	Ser118	LHPPPQLsPFLQPHG	9606									11108261	t		lperfetto	Studies using mutants of er-alpha demonstrated that akt increased estrogen receptor activity through the amino-terminal activation function-1 (af-1). Serines s104 s106, s118, and s167 appear to play a role in the activation of er-alpha by akt.	SIGNOR-244255
SIGNOR-LBC	Luminal Breast Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	ESR1	factor	protein	P03372	UNIPROT	up-regulates	phosphorylation	Ser167	GGRERLAsTNDKGSM	9606									11108261	t		lperfetto	Studies using mutants of er-alpha demonstrated that akt increased estrogen receptor activity through the amino-terminal activation function-1 (af-1). Serines s104 s106, s118, and s167 appear to play a role in the activation of er-alpha by akt.	SIGNOR-244251
SIGNOR-LBC	Luminal Breast Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	Survival	phenotypesList	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606	BTO:0000830								15526160	f		miannu	 c-Kit promotes survival via PI3-kinase-dependent activation of Akt and phosphorylation of Bad, a pro-apoptotic molecule, at S136 in vivo. 	SIGNOR-254952
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	BRAF		protein	P15056	UNIPROT	down-regulates	phosphorylation	Thr401	STTGLSAtPPASLPG	9606									21135229	t		lperfetto	We show that b-raf is a calcineurin substrate;among calcineurin target residues on b-raf is t401, a site of negative feedback phosphorylation by erk1/2. Blocking calcineurin activity in _ cells prevents dephosphorylation of b-raf t401 and decreases b-raf and erk1/2 activities.	SIGNOR-170339
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	JUN	factor	protein	P05412	UNIPROT	up-regulates activity	phosphorylation			9606	BTO:0000675								23616010			lperfetto	The results revealed that PAR2-AP and FVIIa could upregulate c-Jun expression and c-Jun phosphorylation in SW620 cells in a time-dependent manner. The effect of FVIIa was significantly blocked by anti-TF and anti-PAR2 antibodies. Protein kinase C_ (PKC_) inhibitor safingol and extracellular signal-regulated kinase 1 and 2 (ERK1/2) inhibitor U0126 abrogated the activation of c-Jun	SIGNOR-236767
SIGNOR-LBC	Luminal Breast Cancer	mTORC1		complex	SIGNOR-C3	SIGNOR	Cell_growth	phenotypesList	phenotype	SIGNOR-PH33	SIGNOR	up-regulates				9606									23863160	f		lperfetto	Cellular energy and nutrient status will dictate whether mTORC1 takes over and drives cell growth or conversely whether AMPK becomes active once again to drive consecutive waves of autophagy thorough ULK1.	SIGNOR-209919
SIGNOR-LBC	Luminal Breast Cancer	mTORC1		complex	SIGNOR-C3	SIGNOR	mTORC1		complex	SIGNOR-C3	SIGNOR	up-regulates activity	phosphorylation			10090	BTO:0000944								18372248	t		lperfetto	We propose that after mtorc1 kinase activation by upstream regulators, pras40 is phosphorylated directly by mtor, thus contributing to the relief of pras40-mediated substrate competition. We also find that mutation of ser-221 to ala increases the inhibitory activity of pras40 toward mtorc1.	SIGNOR-235518
SIGNOR-LBC	Luminal Breast Cancer	PIK3CA		protein	P42336	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates activity				9606		BTO:0000150							19573809	f		lperfetto	However, here we show through phosphoprotein profiling and functional genomic studies that many PIK3CA mutant cancer cell lines and human breast tumors exhibit only minimal AKT activation and a diminished reliance on AKT for anchorage-independent growth	SIGNOR-236436
SIGNOR-LBC	Luminal Breast Cancer	SOS1		protein	Q07889	UNIPROT	KRAS		protein	P01116	UNIPROT	up-regulates	guanine nucleotide exchange factor			9606									25624485	t	Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.	gcesareni	Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts 	SIGNOR-141647
SIGNOR-LBC	Luminal Breast Cancer	SOS1		protein	Q07889	UNIPROT	KRAS		protein	P01116	UNIPROT	up-regulates	guanine nucleotide exchange factor			9606									25624485	t	Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.	gcesareni	Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts 	SIGNOR-175256
SIGNOR-LBC	Luminal Breast Cancer	PDPK1		protein	O15530	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates activity	phosphorylation			9606									15743829	t		lperfetto	3-phosphoinositide-dependent kinase 1 (PDK1) phosphorylates the activation loop of a number of protein serine/threonine kinases of the AGC kinase superfamily, including protein kinase B (PKB; also called Akt),	SIGNOR-244469
SIGNOR-LBC	Luminal Breast Cancer	PDPK1		protein	O15530	UNIPROT	PDPK1		protein	O15530	UNIPROT	unknown	phosphorylation	Ser396	SSSSSSHsLSASDTG	9606	BTO:0000007								10455013	t		lperfetto	3-phosphoinositide-dependent protein kinase-1 (pdk1) expressed in unstimulated 293 cells was phosphorylated at ser-25, ser-241, ser-393, ser-396 and ser-410 and the level of phosphorylation of each site was unaffected by stimulation with insulin-like growth factor-1. Mutation of ser-241 to ala abolished pdk1 activity, whereas mutation of the other phosphorylation sites individually to ala did not affect pdk1 activity	SIGNOR-236764
SIGNOR-LBC	Luminal Breast Cancer	PTEN		protein	P60484	UNIPROT	PTEN		protein	P60484	UNIPROT	up-regulates activity	dephosphorylation	Thr383	HYRYSDTtDSDPENE	9606	BTO:0000007								22413754	t		miannu	Overall, our results suggest that PTEN autodephosphorylation may be a critical event in this process; thus a major protein substrate for PTEN may be PTEN itself.|Various studies have demonstrated that PTEN is itself a phosphoprotein, and that the major sites of phosphorylation are found in an acidic stretch (DHYRYSDTTDSDPENE) near the C-terminus [1]. This prompted us to consider whether PTEN may autodephosphorylate these sites	SIGNOR-248545
SIGNOR-LBC	Luminal Breast Cancer	PTEN		protein	P60484	UNIPROT	PTEN		protein	P60484	UNIPROT	up-regulates activity	dephosphorylation	Thr382	DHYRYSDtTDSDPEN	9606	BTO:0000007								22413754	t		miannu	Overall, our results suggest that PTEN autodephosphorylation may be a critical event in this process; thus a major protein substrate for PTEN may be PTEN itself.|Various studies have demonstrated that PTEN is itself a phosphoprotein, and that the major sites of phosphorylation are found in an acidic stretch (DHYRYSDTTDSDPENE) near the C-terminus [1]. This prompted us to consider whether PTEN may autodephosphorylate these sites	SIGNOR-248546
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606	BTO:0000876	BTO:0001103							11602185	f		apalma	The GM-CSF promoted cell survival and proliferation correlated with MEK-1 dependent ERK1/2, Elk-1 and CREB phosphorylation and Egr-1, c-Fos expression as well as with increased STAT-5, AP-1, c-Myb and NF-kappaB DNA-binding.	SIGNOR-255580
SIGNOR-LBC	Luminal Breast Cancer	PTEN		protein	P60484	UNIPROT	PTEN		protein	P60484	UNIPROT	up-regulates activity	dephosphorylation	Ser380	EPDHYRYsDTTDSDP	9606	BTO:0000007								22413754	t		miannu	Overall, our results suggest that PTEN autodephosphorylation may be a critical event in this process; thus a major protein substrate for PTEN may be PTEN itself.|Various studies have demonstrated that PTEN is itself a phosphoprotein, and that the major sites of phosphorylation are found in an acidic stretch (DHYRYSDTTDSDPENE) near the C-terminus [1]. This prompted us to consider whether PTEN may autodephosphorylate these sites	SIGNOR-248544
SIGNOR-LBC	Luminal Breast Cancer	PDPK1		protein	O15530	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates activity	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606	BTO:0000567								15718470	t		gcesareni	Akt/PKB activation requires the phosphorylation of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 within the carboxyl-terminal hydrophobic motif by an unknown kinase.	SIGNOR-243203
SIGNOR-LBC	Luminal Breast Cancer	PDPK1		protein	O15530	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates activity	phosphorylation	Thr308	KDGATMKtFCGTPEY	10090									12808134	t		lperfetto	Akt1 and akt2 are phosphorylated and activated by the protein kinase pdk1 at thr-308 or thr-309, respectively, in the activation t-loop, and further activation occurs through phosphorylation at ser-473 or ser-474, respectively. In this paper, we demonstrate that this is indeed the case, and report the purification and initial characterization of a 3 phosphoinositide-dependent protein kinase, pdk1, which activates pkb by phosphorylating it at thr308. Akt is directly phosphorylated and activated by pdk1. Akt/pkb activation requires the phosphorylation of thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (pdk1).	SIGNOR-134477
SIGNOR-LBC	Luminal Breast Cancer	PDPK1		protein	O15530	UNIPROT	PDPK1		protein	O15530	UNIPROT	unknown	phosphorylation	Ser25	VVLCSCPsPSMVRTQ	9606	BTO:0000009								10455013	t		lperfetto	3-phosphoinositide-dependent protein kinase-1 (pdk1) expressed in unstimulated 293 cells was phosphorylated at ser-25, ser-241, ser-393, ser-396 and ser-410 and the level of phosphorylation of each site was unaffected by stimulation with insulin-like growth factor-1. Mutation of ser-241 to ala abolished pdk1 activity, whereas mutation of the other phosphorylation sites individually to ala did not affect pdk1 activity	SIGNOR-236777
SIGNOR-LBC	Luminal Breast Cancer	PDPK1		protein	O15530	UNIPROT	PDPK1		protein	O15530	UNIPROT	unknown	phosphorylation	Ser393	MQVSSSSsSHSLSAS	9606	BTO:0000010								10455013	t		lperfetto	3-phosphoinositide-dependent protein kinase-1 (pdk1) expressed in unstimulated 293 cells was phosphorylated at ser-25, ser-241, ser-393, ser-396 and ser-410 and the level of phosphorylation of each site was unaffected by stimulation with insulin-like growth factor-1. Mutation of ser-241 to ala abolished pdk1 activity, whereas mutation of the other phosphorylation sites individually to ala did not affect pdk1 activity	SIGNOR-235782
SIGNOR-LBC	Luminal Breast Cancer	PDPK1		protein	O15530	UNIPROT	PDPK1		protein	O15530	UNIPROT	unknown	phosphorylation	Ser410	GLPQRSGsNIEQYIH	9606	BTO:0000008								10455013	t		lperfetto	3-phosphoinositide-dependent protein kinase-1 (pdk1) expressed in unstimulated 293 cells was phosphorylated at ser-25, ser-241, ser-393, ser-396 and ser-410 and the level of phosphorylation of each site was unaffected by stimulation with insulin-like growth factor-1. Mutation of ser-241 to ala abolished pdk1 activity, whereas mutation of the other phosphorylation sites individually to ala did not affect pdk1 activity	SIGNOR-236772
SIGNOR-LBC	Luminal Breast Cancer	PIK3CA		protein	P42336	UNIPROT	Survival	phenotypesList	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9534	BTO:0004055								14665640	f		lperfetto	Signal transduction pathways triggered by Tie2 have been extensively examined. Tyr-1101of Tie2 directly associates in a phosphotyrosine (pTyr)-dependent manner with the p85 regulatory subunit of phosphatidylinositol (PI) 3-kinase, which in turn activate PI 3-kinase, leading to cell motility and survival	SIGNOR-242649
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	SOS1		protein	Q07889	UNIPROT	down-regulates	phosphorylation	Ser1178	IMSKHLDsPPAIPPR	9606									20724475	t		lperfetto	ERK activation was sufficient for the SOS1 phosphorylation and resulting inhibition of EGF-induced Ras activation. This result also showed that SOS1 could be phosphorylated by ERK in the absence of association with EGFR at the plasma membrane, which is a phosphotyrosine-dependent process.	SIGNOR-244743
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									24743741	f			Activation of PDGFRα stimulates proliferation of PDGFRα(+) cells through PI3K-Akt and MEK2-MAPK signaling pathways, and aberrant accumulation of PDGFRα(+) cells was conspicuous in muscles of patients with both genetic and non-genetic muscle diseases.	SIGNOR-254374
SIGNOR-LBC	Luminal Breast Cancer	FGFR1	receptor	protein	P11362	UNIPROT	FGFR1	receptor	protein	P11362	UNIPROT	up-regulates	phosphorylation	Tyr280	VEFMCKVySDPQPHI	9606									12601080	t		lperfetto	Fgfr signaling is under the control of tyrosine phosphorylation to elicit activation of cellular signaling cascades. Ligand binding induces receptor dimerization and transphosphorylation. Fgfr1 contains eleven tyrosine residues (tyr154, tyr280, tyr307, tyr463, tyr585, tyr605, tyr653, tyr654, tyr730 and tyr766), some of which are directly involved regulating the activity of the receptor and others bind to activate substrates leading to the activation of various transduction pathways.	SIGNOR-98626
SIGNOR-LBC	Luminal Breast Cancer	RHEB		protein	Q15382	UNIPROT	mTORC1		complex	SIGNOR-C3	SIGNOR	up-regulates activity				9606									19222999	t		lperfetto	Recent studies document that Rheb activates mTORC1 via direct, GTP-dependent interaction with the peptidyl-prolyl-cis/trans-isomerase FKBP38, which is proposed to act as an inhibitor of mTORC1.	SIGNOR-232208
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	ESR1	factor	protein	P03372	UNIPROT	up-regulates	phosphorylation	Ser106	PLNSVSPsPLMLLHP	9606	BTO:0000567								17615152	t		lperfetto	In several estrogen response element-containing genes, the s118a mutation strongly reduced induction by e(2), and u0126 did not further reduce expression. Here, we show that serines 104 (s104) and 106 (s106) are also phosphorylated by mapk in vitro and upon stimulation of mapk activity in vivo.Phosphorylation at serines 104 and 106 by erk1/2 mapk is important for estrogen receptor-alpha activity	SIGNOR-244651
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	ESR1	factor	protein	P03372	UNIPROT	up-regulates	phosphorylation	Ser118	LHPPPQLsPFLQPHG	9606	BTO:0000567								17615152	t		lperfetto	In several estrogen response element-containing genes, the s118a mutation strongly reduced induction by e(2), and u0126 did not further reduce expression. Here, we show that serines 104 (s104) and 106 (s106) are also phosphorylated by mapk in vitro and upon stimulation of mapk activity in vivo.	SIGNOR-244655
SIGNOR-LBC	Luminal Breast Cancer	KRAS		protein	P01116	UNIPROT	PIK3CA		protein	P42336	UNIPROT	up-regulates	binding			9606									21779497	t		gcesareni	Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85./it was also described that ras interacts with pi3k in a direct manner./lysine residue 227 is essential for the interaction of ras with pi3k phosphatidylinositol 3-kinase (pi3k) is one of the main effector pathways of ras, regulating cell growth, cell cycle entry, cell survival, cytoskeleton reorganization, and metabolism.	SIGNOR-175204
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	INSR	receptor	protein	P06213	UNIPROT	up-regulates activity	phosphorylation	Tyr1011	DVFPCSVyVPDEWEV	-1									3166375	t		lperfetto	This approach revealed that insulin stimulates autophosphorylation of the insulin-receptor beta-subunit in vitro on at least seven tyrosine residues distributed among three distinct domainsAt least two further tyrosine residues appeared to be phosphorylated after those in domains 2 and 3. These residues probably residue within a domain lying in close proximity to the inner face of the plasma membrane containing tyrosines 953, 960 and 972	SIGNOR-233564
SIGNOR-LBC	Luminal Breast Cancer	GRB2		protein	P62993	UNIPROT	SOS1		protein	Q07889	UNIPROT	up-regulates activity	relocalization			9606									8479541	t	GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP	lperfetto	Furthermore, our results indicate that the interaction domains of sos1 and grb2 have evolved so as to bind ligands not with maximal strength but with specificities and affinities that maintain cooperativity. Grb2 binds and activates sos, which then activates ras, and this activates p110 independently of p85.	SIGNOR-39163
SIGNOR-LBC	Luminal Breast Cancer	FGFR1	receptor	protein	P11362	UNIPROT	FGFR1	receptor	protein	P11362	UNIPROT	up-regulates	phosphorylation	Tyr463	MLAGVSEyELPEDPR	10116	BTO:0002809;BTO:0001009								8622701	t		lperfetto	In this report, we describe the identification of six additional autophosphorylation sites (y-463, y-583, y-585, y-653, y-654 and y-730) on fgfr1.We have proposed that the role of the third stage of autophosphorylation is to enable the efficient tyrosine phosphorylation of substrate proteins that are physically bound to the receptor molecule by a maximally activated fgfr1	SIGNOR-236179
SIGNOR-LBC	Luminal Breast Cancer	PDPK1		protein	O15530	UNIPROT	PDPK1		protein	O15530	UNIPROT	up-regulates activity	phosphorylation	Ser241	SKQARANsFVGTAQY	9606	BTO:0000007								10455013	t		lperfetto	Pdk1 is itself phosphorylated in vivo and whether phosphorylation plays a role in regulating its activity/ phosphorylation of ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1	SIGNOR-236789
SIGNOR-LBC	Luminal Breast Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	BRAF		protein	P15056	UNIPROT	down-regulates	phosphorylation	Thr440	EDRNRMKtLGRRDSS	9606									10869359	t		lperfetto	We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf	SIGNOR-244156
SIGNOR-LBC	Luminal Breast Cancer	PDPK1		protein	O15530	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates activity	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606		BTO:0000887;BTO:0001103;BTO:0001760							9512493	t		lperfetto	The activation of PKBbeta and PKBamma by PDK11 was accompanied by the phosphorylation of the residues equivalent to Thr308 in PKBalpha, namely Thr309 (PKBbeta) and Thr305 (PKBgamma)	SIGNOR-244480
SIGNOR-LBC	Luminal Breast Cancer	PDPK1		protein	O15530	UNIPROT	PDPK1		protein	O15530	UNIPROT	up-regulates activity	phosphorylation	Ser241	SKQARANsFVGTAQY	9606	BTO:0000007								11481331	t		miannu	In terms of the modulation of PDK1 activity by reversible phosphorylation, five pS sites have been identified on PDK1 in vivo, but only one of these sites, Ser-241 in the activation loop of PDK1, is essential for activity. It seems likely that PDK1 autophosphorylates itself on this residue.	SIGNOR-250268
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	INSR	receptor	protein	P06213	UNIPROT	up-regulates activity	phosphorylation	Tyr1190	DIYETDYyRKGGKGL	-1									2449432	t		lperfetto	We identified the major autophosphorylation sites in the insulin receptor and correlated their phosphorylation with the phosphotransferase activity of the receptor on synthetic peptides. We conclude that 1) autophosphorylation of the insulin receptor begins by phosphorylation of Tyr-1146 and either Tyr-1150 or Tyr-1151;	SIGNOR-106518
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	IRS1		protein	P35568	UNIPROT	up-regulates activity	phosphorylation	Tyr465	GEEELSNyICMGGKG	10116	BTO:0000443								7651388	t		lperfetto	All known IRS proteins contain multiple YXXM motifs that upon phosphorylation by activated insulin receptors A previous study using phosphopeptides suggested that tyrosine-phosphorylated YXXM motifs at positions 608 and 939 in rat IRS-1 bind with high affinity to SH2 domains of p85, and motifs at positions 460 and 987 bind with lower affinity (10).	SIGNOR-236713
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	IRS1		protein	P35568	UNIPROT	up-regulates activity	phosphorylation	Tyr612	TLHTDDGyMPMSPGV	10029	BTO:0000246								7651388	t		lperfetto	Therefore, during insulin stimulation irs-1 undergoes tyrosine phosphorylation, and a portion of tyrosine phosphorylated irs-1 associated with the insulin receptor. The insulin receptor substrate-1 (irs-1) is rapidly phosphorylated on several tyrosine residues by the activated insulin receptor. Insulin signals are mediated through tyrosine phosphorylation of specific proteins such as insulin receptor substrate 1 (irs-1) and shc by the activated insulin receptor (ir).	SIGNOR-236756
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	IRS1		protein	P35568	UNIPROT	up-regulates activity	phosphorylation	Tyr632	GRKGSGDyMPMSPKS	10029	BTO:0000246								7651388	t		lperfetto	Therefore, during insulin stimulation irs-1 undergoes tyrosine phosphorylation, and a portion of tyrosine phosphorylated irs-1 associated with the insulin receptor. The insulin receptor substrate-1 (irs-1) is rapidly phosphorylated on several tyrosine residues by the activated insulin receptor. Insulin signals are mediated through tyrosine phosphorylation of specific proteins such as insulin receptor substrate 1 (irs-1) and shc by the activated insulin receptor (ir).	SIGNOR-236741
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	IRS1		protein	P35568	UNIPROT	up-regulates activity	phosphorylation	Tyr896	EPKSPGEyVNIEFGS	9606	BTO:0000443								12220227	t		lperfetto	Here we show that stimulation by insulin of freshly isolated primary adipocytes resulted in the expected rapid tyrosine phosphorylation of the insulin receptor, IRS-1 and IRS-3. Inhibition of PI 3-kinase enhanced the insulin-stimulated phosphorylation of IRS-1 on (i) Tyr(612) and Tyr(941) (p85 binding sites), concomitant with an increased association of the p85 subunit of PI 3-kinase; (ii) Tyr(896) (a Grb2 binding site); and (iii) Tyr(1229) (an SHP-2 binding site), although little or no binding of SHP-2 to IRS-1 was detectable under any conditions.	SIGNOR-236725
SIGNOR-LBC	Luminal Breast Cancer	JUN	factor	protein	P05412	UNIPROT	CYP19A1		protein	P11511	UNIPROT	up-regulates quantity by expression	transcriptional regulation			9606	BTO:0001555								19022561	f		miannu	We found that both SF1 and LRH1 can transcriptionally cooperate with the AP-1 family members c-JUN and c-FOS, known to be associated with enhanced proliferation of endometrial carcinoma cells, to further enhance activation of the STAR, HSD3B2, and CYP19A1 PII promoters. 	SIGNOR-254876
SIGNOR-LBC	Luminal Breast Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090									16982699	f			Protein kinase B (PKB/Akt) is an important modulator of insulin signaling, cell proliferation, and survival. Using small interfering RNA duplexes in nontransformed mammalian cells, we show that only Akt1 is essential for cell proliferation	SIGNOR-254353
SIGNOR-LBC	Luminal Breast Cancer	PTEN		protein	P60484	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	down-regulates activity				9606	BTO:0001332								19903340	f		lperfetto	PTEN-mediated suppression of the PI3K/AKT pathway is well established, accumulating evidence suggests that nuclear PTEN also plays a critical role in tumor suppression	SIGNOR-244439
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	SOS1		protein	Q07889	UNIPROT	down-regulates activity	phosphorylation	Ser1132	TLPHGPRsASVSSIS	9534	BTO:0004055								8816480	t		lperfetto	In this report, we describe the identification of five map kinase sites (s-1137, s-1167, s-1178, s-1193, and s-1197) on hsos1Replacing the MAP kinase phosphorylation sites with alanine residues results in an increase in the binding affinity of Grb2 to hSos1	SIGNOR-244580
SIGNOR-LBC	Luminal Breast Cancer	CyclinD/CDK4		complex	SIGNOR-C18	SIGNOR	RB1		protein	P06400	UNIPROT	down-regulates activity	phosphorylation	Thr826	LPTPTKMtPRSRILV	9606									9139732	t		lperfetto	We demonstrate that phosphorylation by either cdk2-cyclin a, which phosphorylates t821, or cdk4-cyclin d1, which phosphorylates threonine 826, can disable prb for subsequent binding of an lxcxe protein.	SIGNOR-216957
SIGNOR-LBC	Luminal Breast Cancer	MEK1/2		proteinfamily	SIGNOR-PF25	SIGNOR	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	up-regulates activity	phosphorylation			10090									11730323	t			Raf proteins have been shown to phosphorylate and activate MAPKKs (MAP kinase kinases) called MEKs (MAPK or ERK kinases) which in turn phosphorylate and activate MAPKs (MAP kinases) called ERKs	SIGNOR-258989
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	FGFR1	receptor	protein	P11362	UNIPROT	down-regulates	phosphorylation	Ser777	SMPLDQYsPSFPDTR	9606									23405013	t		lperfetto	Erk-mediated phosphorylation of fibroblast growth factor receptor 1 on ser777 inhibits signaling	SIGNOR-244541
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	JUN	factor	protein	P05412	UNIPROT	up-regulates activity	phosphorylation			9606	BTO:0000762								12509763	t		lperfetto	Substrates for ERK1/2 include nuclear proteins such as C-JUN, this leads to activation of the AP-1 transcription factor, which is made up of FOS-JUN heterodimers.	SIGNOR-253214
SIGNOR-LBC	Luminal Breast Cancer	CyclinD/CDK4		complex	SIGNOR-C18	SIGNOR	RB1		protein	P06400	UNIPROT	down-regulates activity	phosphorylation	Ser795	SPYKFPSsPLRIPGG	9606	BTO:0000150								23336272	t		lperfetto	Cyclin d1 is known to activate cdk4, which then phosphorylates the rb protein, leading to cell cycle progression.	SIGNOR-216992
SIGNOR-LBC	Luminal Breast Cancer	CyclinD/CDK4		complex	SIGNOR-C18	SIGNOR	RB1		protein	P06400	UNIPROT	down-regulates activity	phosphorylation	Ser780	STRPPTLsPIPHIPR	9606	BTO:0000150								23336272	t		lperfetto	Cyclin d1 is known to activate cdk4, which then phosphorylates the rb protein, leading to cell cycle progression.	SIGNOR-216988
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	IRS1		protein	P35568	UNIPROT	up-regulates activity	phosphorylation	Tyr1229	SSEDLSAyASISFQK	9606	BTO:0000443								12220227	t		lperfetto	Here we show that stimulation by insulin of freshly isolated primary adipocytes resulted in the expected rapid tyrosine phosphorylation of the insulin receptor, IRS-1 and IRS-3. Inhibition of PI 3-kinase enhanced the insulin-stimulated phosphorylation of IRS-1 on (i) Tyr(612) and Tyr(941) (p85 binding sites), concomitant with an increased association of the p85 subunit of PI 3-kinase; (ii) Tyr(896) (a Grb2 binding site); and (iii) Tyr(1229) (an SHP-2 binding site), although little or no binding of SHP-2 to IRS-1 was detectable under any conditions.	SIGNOR-235983
SIGNOR-LBC	Luminal Breast Cancer	RHEB		protein	Q15382	UNIPROT	mTORC1		complex	SIGNOR-C3	SIGNOR	up-regulates activity				10090	BTO:0000011								19299511	t		lperfetto	These results suggest that Rheb induces alteration in the binding of 4E-BP1 with mTORC1 to regulate mTORC1 activation.	SIGNOR-235355
SIGNOR-LBC	Luminal Breast Cancer	BRAF		protein	P15056	UNIPROT	MEK1/2		proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates activity	phosphorylation			-1									8413257	t		lperfetto	Raf-1 phosphorylation of MEK activated it, as judged by its ability to stimulate the phosphorylation of myelin basic protein by glutathione S-transferase-ERK1.	SIGNOR-244831
SIGNOR-LBC	Luminal Breast Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	MDM2		protein	Q00987	UNIPROT	up-regulates activity	phosphorylation	Ser186	RQRKRHKsDSISLSF	9606									11504915	t		lperfetto	Mitogen-induced activation of phosphatidylinositol 3-kinase (pi3-kinase) and its downstream target, the akt/pkb serine-threonine kinase, results in phosphorylation of mdm2 on serine 166 and serine 186. Phosphorylation on these sites is necessary for translocation of mdm2 from the cytoplasm into the nucleus.Both akt expression and serum treatment induced phosphorylation of mdm2 at ser186.	SIGNOR-244292
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	INSR	receptor	protein	P06213	UNIPROT	up-regulates activity	phosphorylation	Tyr1185	FGMTRDIyETDYYRK	-1									2449432	t		lperfetto	We identified the major autophosphorylation sites in the insulin receptor and correlated their phosphorylation with the phosphotransferase activity of the receptor on synthetic peptides. We conclude that 1) autophosphorylation of the insulin receptor begins by phosphorylation of Tyr-1146 and either Tyr-1150 or Tyr-1151;	SIGNOR-106510
SIGNOR-LBC	Luminal Breast Cancer	IRS1		protein	P35568	UNIPROT	GRB2		protein	P62993	UNIPROT	up-regulates activity	binding			9606	BTO:0000156								11259577	t		lperfetto	Association ofinsulinreceptor substrate 1 (irs-1) y895 with grb-2 mediates theinsulinsignaling involved in irs-1-deficient brown adipocyte mitogenesis.	SIGNOR-236614
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	INSR	receptor	protein	P06213	UNIPROT	up-regulates activity	phosphorylation	Tyr999	YASSNPEyLSASDVF	-1									3166375	t		lperfetto	This approach revealed that insulin stimulates autophosphorylation of the insulin-receptor beta-subunit in vitro on at least seven tyrosine residues distributed among three distinct domainsAt least two further tyrosine residues appeared to be phosphorylated after those in domains 2 and 3. These residues probably residue within a domain lying in close proximity to the inner face of the plasma membrane containing tyrosines 953, 960 and 972	SIGNOR-106526
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	INSR	receptor	protein	P06213	UNIPROT	up-regulates activity	phosphorylation	Tyr1355	SLGFKRSyEEHIPYT	-1									3166375	t		lperfetto	This approach revealed that insulin stimulates autophosphorylation of the insulin-receptor beta-subunit in vitro on at least seven tyrosine residues distributed among three distinct domainsAt least two further tyrosine residues appeared to be phosphorylated after those in domains 2 and 3. These residues probably residue within a domain lying in close proximity to the inner face of the plasma membrane containing tyrosines 953, 960 and 972	SIGNOR-22577
SIGNOR-LBC	Luminal Breast Cancer	CDKN2A		protein	P42771	UNIPROT	CyclinD/CDK4		complex	SIGNOR-C18	SIGNOR	down-regulates activity	binding			9606									11154267	t		lperfetto	Overexpression of p16INK4a in cells with functional pRb results in inhibition of both Cdk4- and Cdk6-associated kinase activity and pRb phosphorylation, with subsequent cell cycle arrest (46, 50). In addition, inhibition of D cyclin-Cdk4 complex formation by p16INK4a prevents sequestration of p21Cip1 and p27Kip1 by these complexes in early G1, leading to suppression of cyclin E-Cdk2 activity	SIGNOR-245459
SIGNOR-LBC	Luminal Breast Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	BRAF		protein	P15056	UNIPROT	down-regulates	phosphorylation	Ser428	GPQRERKsSSSSEDR	9606									10869359	t		lperfetto	We show that phosphorylation of b-raf by akt occurs at multiple residues within its amino terminal regulatory domain, at both the conserved and unique phosphorylation sites. Akt phosphorylated b-raf on s364 and s428 to inactivate its kinase activity b-raf contains three akt consensus sites, table i. One site, ser364 is conserved with c-raf;however, two sites, ser428 and thr439, are unique to b-raf	SIGNOR-244160
SIGNOR-LBC	Luminal Breast Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	MDM2		protein	Q00987	UNIPROT	up-regulates activity	phosphorylation	Ser166	SSRRRAIsETEENSD	9606		BTO:0000671							15169778	t		lperfetto	Stabilization of mdm2 via decreased ubiquitination is mediated by protein kinase b/akt-dependent phosphorylation.	SIGNOR-244296
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	INSR	receptor	protein	P06213	UNIPROT	up-regulates activity	phosphorylation	Tyr1189	RDIYETDyYRKGGKG	-1									2449432	t		lperfetto	We identified the major autophosphorylation sites in the insulin receptor and correlated their phosphorylation with the phosphotransferase activity of the receptor on synthetic peptides. We conclude that 1) autophosphorylation of the insulin receptor begins by phosphorylation of Tyr-1146 and either Tyr-1150 or Tyr-1151;	SIGNOR-106514
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	INSR	receptor	protein	P06213	UNIPROT	up-regulates activity	phosphorylation	Tyr992	DGPLGPLyASSNPEY	-1									3166375	t		lperfetto	This approach revealed that insulin stimulates autophosphorylation of the insulin-receptor beta-subunit in vitro on at least seven tyrosine residues distributed among three distinct domainsAt least two further tyrosine residues appeared to be phosphorylated after those in domains 2 and 3. These residues probably residue within a domain lying in close proximity to the inner face of the plasma membrane containing tyrosines 953, 960 and 972	SIGNOR-106522
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	IRS1		protein	P35568	UNIPROT	up-regulates activity	phosphorylation	Tyr1229	SSEDLSAyASISFQK	10029	BTO:0000246								7651388	t		lperfetto	Therefore, during insulin stimulation irs-1 undergoes tyrosine phosphorylation, and a portion of tyrosine phosphorylated irs-1 associated with the insulin receptor. The insulin receptor substrate-1 (irs-1) is rapidly phosphorylated on several tyrosine residues by the activated insulin receptor. Insulin signals are mediated through tyrosine phosphorylation of specific proteins such as insulin receptor substrate 1 (irs-1) and shc by the activated insulin receptor (ir).	SIGNOR-236752
SIGNOR-LBC	Luminal Breast Cancer	RB1		protein	P06400	UNIPROT	G1/S_transition	phenotypesList	phenotype	SIGNOR-PH50	SIGNOR	down-regulates				9606									21524151	f		lperfetto	In its hypophosphorylated state, pRb binds transcription factors of the E2F family which are required for cell cycle progression. As the level of CyclinD/Cdk4/6 complexes increases, pRb becomes phosphorylated and progression through G1 occurs. At a critical level of phosphorylation, E2F is released from pRb. This activates the transcription of CyclinE which complexes with Cdk2 to fully release pRb repression by further phosphorylation, establishing a positive feedback loop. E2F further promotes the transcription of S-phase genes. Thus, CyclinD/Cdk4/6 and CyclinE/Cdk2 together regulate S-phase entry via phosphorylating pRb, which controls pRb binding to E2F	SIGNOR-245483
SIGNOR-LBC	Luminal Breast Cancer	FGFR1	receptor	protein	P11362	UNIPROT	FGFR1	receptor	protein	P11362	UNIPROT	up-regulates	phosphorylation	Tyr766	ALTSNQEyLDLSMPL	10116	BTO:0003293								19224897	t		lperfetto	This second-stage autophosphorylation occurs on y583, in the kinase insert region (a noncatalytic sequence within the kinase domain), followed by autophosphorylation of y463 in the juxtamembrane region, y766 in the c-terminal tail, and y585 in the kinase insert region (1). The third-stage autophosphorylation takes place on the second tyrosine in the activation loop (y654), resulting in an additional 10-fold increase in the intrinsic tyrosine kinase activity of fgfr1.	SIGNOR-236203
SIGNOR-LBC	Luminal Breast Cancer	CDKN2A		protein	P42771	UNIPROT	CyclinD/CDK4		complex	SIGNOR-C18	SIGNOR	down-regulates activity	binding			9606									8891723	t		lperfetto	The first group, including p16ink4a, p15ink4b,p18ink4cand p19ink4d, is specific for the g1 cdks,cdk4and cdk6, inhibiting the kinase activity of cyclin d/cdk4-cdk6 complexes on prb.	SIGNOR-217514
SIGNOR-LBC	Luminal Breast Cancer	FGFR1	receptor	protein	P11362	UNIPROT	FGFR1	receptor	protein	P11362	UNIPROT	up-regulates	phosphorylation	Tyr583	RRPPGLEyCYNPSHN	10116	BTO:0002809;BTO:0001009								8622701	t		lperfetto	In this report, we describe the identification of six additional autophosphorylation sites (y-463, y-583, y-585, y-653, y-654 and y-730) on fgfr1.We have proposed that the role of the third stage of autophosphorylation is to enable the efficient tyrosine phosphorylation of substrate proteins that are physically bound to the receptor molecule by a maximally activated fgfr1	SIGNOR-236183
SIGNOR-LBC	Luminal Breast Cancer	KRAS		protein	P01116	UNIPROT	BRAF		protein	P15056	UNIPROT	up-regulates activity	binding			9606									21779497	t		miannu	The raf family of proteins (raf-1, a-raf, and b-raf) is serine/threonine kinases that bind to the effector region of ras-gtp, thus inducing translocation of the protein to the plasma membrane. Once there, raf proteins are activated and phosphorylated by different protein kinases.	SIGNOR-156906
SIGNOR-LBC	Luminal Breast Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	MDM2		protein	Q00987	UNIPROT	up-regulates activity	phosphorylation	Ser188	RKRHKSDsISLSFDE	9606		BTO:0000671							15169778	t		lperfetto	Stabilization of mdm2 via decreased ubiquitination is mediated by protein kinase b/akt-dependent phosphorylationhere we show that pkb inhibits mdm2 self-ubiquitination via phosphorylation of mdm2 on ser(166) and ser(188)	SIGNOR-244300
SIGNOR-LBC	Luminal Breast Cancer	GRB2		protein	P62993	UNIPROT	SOS1		protein	Q07889	UNIPROT	up-regulates activity	relocalization			10090	BTO:0000669								23452850	t	GRB2 associated guanine nucleotide exchange factor Sos activates Ras through the exchange of GDP for GTP	lperfetto	Interaction domains of sos1/grb2 are finely tuned for cooperative control of embryonic stem cell fate.	SIGNOR-235773
SIGNOR-LBC	Luminal Breast Cancer	FGFR1	receptor	protein	P11362	UNIPROT	FGFR1	receptor	protein	P11362	UNIPROT	up-regulates	phosphorylation	Tyr585	PPGLEYCyNPSHNPE	10116	BTO:0002809;BTO:0001009								8622701	t		lperfetto	In this report, we describe the identification of six additional autophosphorylation sites (y-463, y-583, y-585, y-653, y-654 and y-730) on fgfr1.We have proposed that the role of the third stage of autophosphorylation is to enable the efficient tyrosine phosphorylation of substrate proteins that are physically bound to the receptor molecule by a maximally activated fgfr1	SIGNOR-236187
SIGNOR-LBC	Luminal Breast Cancer	FGFR1	receptor	protein	P11362	UNIPROT	FGFR1	receptor	protein	P11362	UNIPROT	up-regulates	phosphorylation	Tyr654	DIHHIDYyKKTTNGR	10116	BTO:0002809;BTO:0001009								8622701	t		lperfetto	In this report, we describe the identification of six additional autophosphorylation sites (y-463, y-583, y-585, y-653, y-654 and y-730) on fgfr1. We demonstrate that autophosphorylation on tyrosines 653 and 654 is important for activation of tyrosine kinase activity of fgfr1 and is therefore essential for fgfr1-mediated biological responses.	SIGNOR-236199
SIGNOR-LBC	Luminal Breast Cancer	SOS1		protein	Q07889	UNIPROT	KRAS		protein	P01116	UNIPROT	up-regulates	guanine nucleotide exchange factor			9606									25624485	t	Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.	gcesareni	Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts 	SIGNOR-201703
SIGNOR-LBC	Luminal Breast Cancer	BRAF		protein	P15056	UNIPROT	MEK1/2		proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates activity	phosphorylation			9606									21900390	t		miannu	BRAFV600E has been shown to initiate thyroid follicular cell transformation. The BRAFV600E mutation disrupts the hydrophobic interaction, enabling the BRAF kinase to fold into a catalytically active formation, resulting in an almost 500-fold increase in kinase activity. Mutant BRAF can dimerize and activate MEK without Ras activation.	SIGNOR-251988
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									19819937	f			In addition to the JAK2–STAT5 pathway, the Ras GTPase–extracellular signal-regulated kinase (Ras–ERK) pathway has also been implicated in signaling of IL-5 and is important for IL-5-dependent cell survival, proliferation and differentiation of eosinophils. 	SIGNOR-254354
SIGNOR-LBC	Luminal Breast Cancer	PIK3CA		protein	P42336	UNIPROT	IRS1		protein	P35568	UNIPROT	down-regulates activity				9606									11160134	f		lperfetto	Ly294002 or wortmannin were used to determine whether pi 3-kinasedependent pathways mediate ser307 phosphorylation during insulin/igf-1 or TNF-alpha Stimulation. As expected, the pi-3 kinase inhibitors ly294002 or wortmannin inhibited activation of pkb/akt in insulin or igf-1 stimulated 3t3-l1 preadipocytes, but were without effect on erk1/2.  these results suggest that elements of the pi 3-kinase cascade mediate insulin/igf-1stimulated phosphorylation of ser307	SIGNOR-104911
SIGNOR-LBC	Luminal Breast Cancer	MEK1/2		proteinfamily	SIGNOR-PF25	SIGNOR	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	up-regulates	phosphorylation			9606									11971971	t		lperfetto	Mapk1 is phosphorylated by map2k1/mek1 and map2k2/mek2 on thr-185 and tyr-187 in response to external stimuli like insulin or ngf. Both phosphorylations are required for activity.	SIGNOR-244776
SIGNOR-LBC	Luminal Breast Cancer	FGFR1	receptor	protein	P11362	UNIPROT	FGFR1	receptor	protein	P11362	UNIPROT	up-regulates	phosphorylation	Tyr154	NRMPVAPyWTSPEKM	9606									8443592	t		lperfetto	Tyrosine residues 154 and 307, which are in the extracellular domain of transmembrane receptor isoforms and are in an unusual sequence context for tyrosine phosphorylation, were also phosphorylated.	SIGNOR-98622
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	Survival	phenotypesList	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606	BTO:0000830								15526160	f			Numerous studies have implicated the critical importance of the Ras/Erk pathway in cell division and survival	SIGNOR-254948
SIGNOR-LBC	Luminal Breast Cancer	FRS2	receptor	protein	Q8WU20	UNIPROT	GRB2		protein	P62993	UNIPROT	up-regulates activity	binding			10116	BTO:0002809								9182757	t		fspada	In this report, we demonstrate that FGF stimulation induces tyrosine phosphorylation of a novel lipid anchored docking protein, termed FRS2, that forms a complex with Grb2/Sos, thus linking FGF-receptor activation to the Ras/MAPK signaling pathway.	SIGNOR-236953
SIGNOR-LBC	Luminal Breast Cancer	E2F1	factor	protein	Q01094	UNIPROT	G1/S_transition	phenotypesList	phenotype	SIGNOR-PH50	SIGNOR	up-regulates				9606									21524151	f		lperfetto	In its hypophosphorylated state, pRb binds transcription factors of the E2F family which are required for cell cycle progression. As the level of CyclinD/Cdk4/6 complexes increases, pRb becomes phosphorylated and progression through G1 occurs. At a critical level of phosphorylation, E2F is released from pRb. This activates the transcription of CyclinE which complexes with Cdk2 to fully release pRb repression by further phosphorylation, establishing a positive feedback loop. E2F further promotes the transcription of S-phase genes. Thus, CyclinD/Cdk4/6 and CyclinE/Cdk2 together regulate S-phase entry via phosphorylating pRb, which controls pRb binding to E2F	SIGNOR-245477
SIGNOR-LBC	Luminal Breast Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	TSC1/TSC2		complex	SIGNOR-C101	SIGNOR	down-regulates activity	phosphorylation			10090	BTO:0000011								19593385	t		lperfetto	In examining the requirements for different Akt-mediated phosphorylation sites on TSC2, we find that only TSC2 mutants lacking all five previously identified Akt sites fully block insulin-stimulated mTORC1 signaling in reconstituted Tsc2 null cells, and this mutant also inhibits adipogenesis	SIGNOR-251526
SIGNOR-LBC	Luminal Breast Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	mTORC1		complex	SIGNOR-C3	SIGNOR	up-regulates activity	phosphorylation			10090	BTO:0000011								19593385	t		lperfetto	In examining the requirements for different Akt-mediated phosphorylation sites on TSC2, we find that only TSC2 mutants lacking all five previously identified Akt sites fully block insulin-stimulated mTORC1 signaling in reconstituted Tsc2 null cells, and this mutant also inhibits adipogenesis	SIGNOR-252817
SIGNOR-LBC	Luminal Breast Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	mTORC1		complex	SIGNOR-C3	SIGNOR	up-regulates activity	phosphorylation			9606		BTO:0000887;BTO:0001103;BTO:0001760							20138985	t		lperfetto	Pras40 is an insulin-regulated inhibitor of the mtorc1 protein kinase. Insulin stimulates akt/pkb-mediated phosphorylation of pras40, which prevents its inhibition of mtorc1 in cells and in vitro. Phosphorylation of pras40 on thr246 by pkb/akt facilitates efficient phosphorylation of ser183 by mtorc1.	SIGNOR-217586
SIGNOR-LBC	Luminal Breast Cancer	FGFR1	receptor	protein	P11362	UNIPROT	FGFR1	receptor	protein	P11362	UNIPROT	up-regulates	phosphorylation	Tyr585	PPGLEYCyNPSHNPE	10116	BTO:0003293								19224897	t		lperfetto	Autophosphorylation of Y653 is followed by the ordered autophosphorylation of several key tyrosine residues within binding sites for the SH2 or PTB domains of signaling proteins that bind to and are phosphorylated by activated FGFR1. This second-stage autophosphorylation occurs on Y583, in the kinase insert region (a noncatalytic sequence within the kinase domain), followed by autophosphorylation of Y463 in the juxtamembrane region, Y766 in the C-terminal tail, and Y585 in the kinase insert region	SIGNOR-235682
SIGNOR-LBC	Luminal Breast Cancer	FGFR1	receptor	protein	P11362	UNIPROT	FGFR1	receptor	protein	P11362	UNIPROT	up-regulates	phosphorylation	Tyr730	SNCTNELyMMMRDCW	10116	BTO:0002809;BTO:0001009								8622701	t		lperfetto	In this report, we describe the identification of six additional autophosphorylation sites (y-463, y-583, y-585, y-653, y-654 and y-730) on fgfr1.We have proposed that the role of the third stage of autophosphorylation is to enable the efficient tyrosine phosphorylation of substrate proteins that are physically bound to the receptor molecule by a maximally activated fgfr1	SIGNOR-235686
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	ESR1	factor	protein	P03372	UNIPROT	up-regulates	phosphorylation	Ser104	FPPLNSVsPSPLMLL	9606	BTO:0000567								17615152	t		lperfetto	In several estrogen response element-containing genes, the s118a mutation strongly reduced induction by e(2), and u0126 did not further reduce expression. Here, we show that serines 104 (s104) and 106 (s106) are also phosphorylated by mapk in vitro and upon stimulation of mapk activity in vivo.Phosphorylation at serines 104 and 106 by erk1/2 mapk is important for estrogen receptor-alpha activity	SIGNOR-244647
SIGNOR-LBC	Luminal Breast Cancer	PIK3CA		protein	P42336	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates activity	phosphorylation			9606									12167717	t		lperfetto	PKB induction requires phosphorylation of two critical residues, threonine 308 in the activation loop and serine 473 near the carboxyl terminus. Membrane localization of PKB was found to be a primary determinant of serine 473 phosphorylation. PI3K activity was equally important for promoting phosphorylation of serine 473,	SIGNOR-244429
SIGNOR-LBC	Luminal Breast Cancer	PTEN		protein	P60484	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	down-regulates activity				9606	BTO:0001271								20596030	f		lperfetto	Exposure of eol-1r cells to imatinib failed to dephosphorylate akt, erk and stat5, although pdgfralpha was effectively inactivated. The forced expression of pten negatively regulated these signal pathways and sensitized eol-1r cells to imatinib.	SIGNOR-166478
SIGNOR-LBC	Luminal Breast Cancer	JUN	factor	protein	P05412	UNIPROT	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									9878062	f		lperfetto	Functional data suggest that c-Jun is not merely a target for activation by many of the extracellular stimuli, but that it plays a role in mediating the cellular response. In the case of growth control, three lines of evidence suggest that the transcription factor AP-1, which is composed of FosJun and JunJun dimers, mediates cell proliferation in response to external growth signals in the form of peptide growth factors.	SIGNOR-233467
SIGNOR-LBC	Luminal Breast Cancer	FGFR1	receptor	protein	P11362	UNIPROT	FGFR1	receptor	protein	P11362	UNIPROT	up-regulates	phosphorylation	Tyr463	MLAGVSEyELPEDPR	10116	BTO:0003293								19224897	t		lperfetto	This second-stage autophosphorylation occurs on Y583, in the kinase insert region (a noncatalytic sequence within the kinase domain), followed by autophosphorylation of Y463 in the juxtamembrane region, Y766 in the C-terminal tail, and Y585 in the kinase insert region	SIGNOR-235762
SIGNOR-LBC	Luminal Breast Cancer	FGFR1	receptor	protein	P11362	UNIPROT	FGFR1	receptor	protein	P11362	UNIPROT	up-regulates	phosphorylation	Tyr653	RDIHHIDyYKKTTNG	10116	BTO:0002809;BTO:0001009								8622701	t		lperfetto	In this report, we describe the identification of six additional autophosphorylation sites (y-463, y-583, y-585, y-653, y-654 and y-730) on fgfr1. We demonstrate that autophosphorylation on tyrosines 653 and 654 is important for activation of tyrosine kinase activity of fgfr1 and is therefore essential for fgfr1-mediated biological responses.	SIGNOR-236195
SIGNOR-LBC	Luminal Breast Cancer	FGFR1	receptor	protein	P11362	UNIPROT	FGFR1	receptor	protein	P11362	UNIPROT	up-regulates	phosphorylation	Tyr730	SNCTNELyMMMRDCW	10116	BTO:0003293								19224897	t		lperfetto	Furthermore, under conditions in which wild-type or mutant FGFR1 are overexpressed, Y463, Y583, Y585, and Y730 are dispensable for tyrosine phosphorylation of Shc, the mitogen-activated protein kinase (MAPK) response, and stimulation of FGFR1-mediated cell proliferation and differentiation	SIGNOR-236191
SIGNOR-LBC	Luminal Breast Cancer	TP53	factor	protein	P04637	UNIPROT	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606	BTO:0000452								7667317	f			P53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts	SIGNOR-255669
SIGNOR-LBC	Luminal Breast Cancer	SOS1		protein	Q07889	UNIPROT	KRAS		protein	P01116	UNIPROT	up-regulates	guanine nucleotide exchange factor			9606									25624485	t	Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.	gcesareni	Because the KRAS-GDP to KRAS-GTP transition catalyzed by the GEF, son of sevenless 1 (SOS1), represents the rate-limiting step for nucleotide exchange, disrupting the activating SOS1/KRAS protein interaction has also been the focus of drug development efforts 	SIGNOR-122075
SIGNOR-LBC	Luminal Breast Cancer	INSR	receptor	protein	P06213	UNIPROT	IRS1		protein	P35568	UNIPROT	up-regulates activity	phosphorylation	Tyr632	GRKGSGDyMPMSPKS	10116	BTO:0000443								11416002	t		lperfetto	All known IRS proteins contain multiple YXXM motifs that upon phosphorylation by activated insulin re- ceptors Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells	SIGNOR-236709
SIGNOR-LBC	Luminal Breast Cancer	BRAF		protein	P15056	UNIPROT	MEK1/2		proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates activity	phosphorylation			10090	BTO:0000944								8131746	t		lperfetto	Activation of mek family kinases requires phosphorylation of two conserved ser/thr residueserine residues 218 and 222 of human mek1 are the primary sites for phosphorylation by c-raf.	SIGNOR-244827
SIGNOR-LBC	Luminal Breast Cancer	BRAF		protein	P15056	UNIPROT	MEK1/2		proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates	phosphorylation			9606		BTO:0000142							8668348	t		lperfetto	We show that, consequently, b-raf interacts with mek-1 and mek-2 with a better affinity than does c-raf-1, thus strengthening the notion that b-raf is a stronger mek activator than c-raf-l.	SIGNOR-244843
SIGNOR-LBC	Luminal Breast Cancer	ERK1/2		proteinfamily	SIGNOR-PF1	SIGNOR	MEK1/2		proteinfamily	SIGNOR-PF25	SIGNOR	down-regulates activity	phosphorylation			9606	BTO:0000007								10567369	t		lperfetto	An ERK2-binding site at the N terminus of MEK1 was reported to mediate their stable association. We examined the importance of this binding site in the feedback phosphorylation of mek1 on thr(292) and thr(386) by erk2	SIGNOR-244858
SIGNOR-LBC	Luminal Breast Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	ESR1	factor	protein	P03372	UNIPROT	up-regulates	phosphorylation	Ser104	FPPLNSVsPSPLMLL	9606									11108261	t		lperfetto	Studies using mutants of er-alpha demonstrated that akt increased estrogen receptor activity through the amino-terminal activation function-1 (af-1). Serines s104 s106, s118, and s167 appear to play a role in the activation of er-alpha by akt.	SIGNOR-244243
SIGNOR-LBC	Luminal Breast Cancer	PDPK1		protein	O15530	UNIPROT	PDPK1		protein	O15530	UNIPROT	down-regulates activity	phosphorylation	Ser241	SKQARANsFVGTAQY	-1									12177059	t		miannu	PDK1 kinase activity is negatively regulated by binding to 14-3-3 through the PDK1 autophosphorylation site Ser-241. PDK1 binds to 14-3-3 in vivo and in vitro through the residues surrounding the autophosphorylation site Ser-241 and that the association is achieved only when Ser-241 has been phosphorylated 	SIGNOR-250077
SIGNOR-LBC	Luminal Breast Cancer	mTORC1		complex	SIGNOR-C3	SIGNOR	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0000007							20508131	f			The mammalian target of rapamycin complex 1 (mTORC1) integrates mitogen and nutrient signals to control cell proliferation and cell size.	SIGNOR-256063
SIGNOR-LBC	Luminal Breast Cancer	mTORC1		complex	SIGNOR-C3	SIGNOR	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0001103							15829723	f		apalma	Phosphorylation of mTOR by Akt leads to mTOR activation (40, 52) and the subsequent activation of p70S6K (47). This latter event has great potential importance for the promotion of muscle growth by the IGF-I/Akt/mTOR pathway, because p70S6k is a potent stimulator of protein synthesis that can be activated by increases in muscle contraction	SIGNOR-256064
SIGNOR-LBC	Luminal Breast Cancer	FGFR1	receptor	protein	P11362	UNIPROT	MEK1/2		proteinfamily	SIGNOR-PF25	SIGNOR	up-regulates				9606									12270934	f		lperfetto	Fibroblast growth factor-2 (FGF-2), in the presence of dexamethasone, isobutylmethylxanthine, and insulin, induces a prolonged activation of the MEK/ERK signaling pathway, which lasts for at least 12 h post-induction, and this activity is less sensitive to the MEK inhibitors	SIGNOR-244865
SIGNOR-LBC	Luminal Breast Cancer	RB1		protein	P06400	UNIPROT	E2F1	factor	protein	Q01094	UNIPROT	down-regulates activity	binding			9606									8255752	t		amattioni	E2f binds rb. E2f activation domain is the target for rb-induced repression. Rb can silence the 57 residue e2f activation domain. Rb can mask e2f residues involved in the activation process, possibly by mimicking a component of the transcriptional machinery	SIGNOR-37305
